DNA damage by free radical production by aminoguanidine

Annals of the New York Academy of Sciences

Volumn 1067, Issue 1, 2006, Pages 191-199

  Suji, George ^a   Sivakami, Subramanium ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

Aminoguanidine; Diabetes mellitus; DNA damage; Free radicals; Prooxidant

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; CARBONYL DERIVATIVE; FERRIC ION; FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; METAL ION; PLASMID DNA; SCAVENGER; TRANSITION ELEMENT;

CONFERENCE PAPER; DIABETES MELLITUS; DNA DAMAGE; DNA SUPERCOILING; DRUG SAFETY; GLYCATION;

EID: 33744458972     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1354.023     Document Type: Conference Paper

References (19)

1. Thornalley, P.J. 2003. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys. 419: 31 40.
2. Hirsch, E.P. & M.S. Feather. 1992. The reaction of some dicarbonyl sugars with aminoguanidine. Carbohyd. Res. 232: 125 130.
3. Brownlee, M., H. Vlassara, A. Kooney, et al. 1986. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629 1632.
4. Requena, J.R., P. Vidal & J. Cabezas-Cerrato. 1993. Aminoguanidine inhibits protein browning without extensive Amadori carbonyl blocking. Diabetes Res. Clin. Pract. 19: 23 30.
5. Hames, H., S. Martin, K. Federlin, et al. 1991. Aminoguanidine inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. USA 88: 11555 11558.
6. Edelstein, D. & M. Brownlee. 1992. Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 35: 96 97.
7. Ou, P. & S.P. Wolff. 1993. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol. 46: 1139 1144.
8. Sagripanti, J-L. & K.H. Kraemerll. 1969. Site-specific oxidative DNA damage at polyguanosines produced by copper plus hydrogen peroxide. J. Biol. Chem. 264: 1729 1734.
9. Kang, J.H. 2003. Oxidative damage of DNA by the reaction of amino acid with methylglyoxal in the presence of Fe(III). Int. J. Biol. Macromol. 33: 43 48.
10. Hunt, J.V., R.T. Dean & S.P. Wolff. 1988. Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem. J. 256: 205 212.
11. Beauchamp, C. & I. Fridovich. 1971. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44: 276 287.
12. Jiang, Z.Y., A.C. Woollard & S.P. Wolff. 1990. Hydrogen peroxide production during experimental protein glycation. FEBS Lett. 268: 69 71.
13. Philis-Tsimikas, A., S. Parthasarathy, S. Picard, et al. 1994. Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler. Thromb. Vasc. Biol. 15: 367 376.
14. Skamarauskas, J.T., A.G. McKay & J.V. Hunt. 1996. Aminoguanidine and its pro-oxidant effects on an experimental model of protein glycation. Free Radic. Biol. Med. 21: 801 812.
15. Cutler, P. 1989. Deferoxamine therapy in high-ferritin diabetes. Diabetes 38: 1207 1210.
16. Thomas, M.C., R.J. MacIsaac, C. Tsalamandris, et al. 2004. Elevated iron indices in patients with diabetes. Diabet. Med. 21: 798 802.
17. Salonen, J.T., T-P. Tuomainen, K. Nyyssönen, et al. 1998. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 317: 727 730.
18. Baylin, S., Z. Horakova & M.A. Beaven. 1975. Increase in food consumption and growth after treatment with aminoguanidine. Experientia 31: 562 564.
19. Lo, T.W., T. Selwood & P.J. Thornalley. 1994. The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins. Biochem. Pharmacol. 48: 1865 1870.